Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation

Molecular Cell
Gregor SchaffarF Ulrich Hartl

Abstract

The expression of polyglutamine-expanded mutant proteins in Huntington's disease and other neurodegenerative disorders is associated with the formation of intraneural inclusions. These aggregates could potentially cause cellular toxicity by sequestering essential proteins possessing normal polyQ repeats, including the transcription factors TBP and CBP. We show, in vitro and in cells, that monomers or small soluble oligomers of huntingtin exon1 accumulate in the nucleus and inhibit the function of TBP in a polyQ-dependent manner. FRET experiments indicate that these toxic forms are generated through a conformational rearrangement in huntingtin. Interaction of toxic huntingtin with the benign polyQ repeat of TBP structurally destabilizes the transcription factor, independent of the formation of insoluble coaggregates. Hsp70/Hsp40 chaperones interfere with the conformational change in mutant huntingtin and inhibit the deactivation of TBP. These results outline a molecular mechanism of cellular toxicity in polyQ disease and can explain the beneficial effects of molecular chaperones.

References

Sep 11, 1990·Nucleic Acids Research·S Mizushima, S Nagata
Dec 16, 1998·The Journal of Cell Biology·M K PerezR N Pittman
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·S Krobitsch, S Lindquist
Jun 9, 2000·Annual Review of Neuroscience·H Y Zoghbi, H T Orr
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·P J MuchowskiF U Hartl
Aug 25, 2000·Human Molecular Genetics·A McCampbellK H Fischbeck
Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·R S RajanR R Kopito
Jan 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Paul J MuchowskiStanley Fields
Mar 21, 2002·FEBS Letters·Laura MasinoAnnalisa Pastore
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·M F PerutzA Lesk
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yaohui ChaiHenry L Paulson
Aug 15, 2002·Structure·Ronald Wetzel
Aug 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hideki SakahiraF Ulrich Hartl
Oct 3, 2002·Nature Cell Biology·Soojin KimRichard I Morimoto
Apr 25, 2003·Trends in Genetics : TIG·Katharine L Sugars, David C Rubinsztein

❮ Previous
Next ❯

Citations

Mar 11, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Motomasa TanakaNobuyuki Nukina
Sep 12, 2006·Biogerontology·Mehmet Alper ArslanCsaba Soti
May 31, 2007·Journal of Biosciences·C Söti, Péter Csermely
May 31, 2007·Journal of Biosciences·Brian R BettencourtMario Nimali
Apr 18, 2008·The Cerebellum·Olaf RiessLudger Schöls
May 27, 2005·Neuroscience·W M C van Roon-MomR G Snell
Jun 19, 2013·Trends in Biochemical Sciences·John Labbadia, Richard I Morimoto
May 2, 2008·Chemical Reviews·Andras Bauer, Brent Stockwell
Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ryan L BoudreauBeverly L Davidson
Aug 30, 2008·Nature·Daniel KaganovichJudith Frydman
Aug 2, 2005·Nature Cell Biology·Amie J McClellanJudith Frydman
Sep 19, 2006·Nature Cell Biology·Akira KitamuraKazuhiro Nagata
Nov 1, 2011·Nature Chemical Biology·Jason MillerSteven Finkbeiner
Nov 13, 2013·Nature Communications·Julia LeitmanGerardo Z Lederkremer
Aug 26, 2006·Nature Clinical Practice. Neurology·Ghazaleh Sadri-Vakili, Jang-Ho J Cha
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Nov 17, 2009·Nature Structural & Molecular Biology·Stephen TamJudith Frydman
Mar 21, 2007·Nature Structural & Molecular Biology·Yoshitaka NagaiTatsushi Toda
Nov 16, 2004·Nature Structural & Molecular Biology·Jennifer L WackerPaul J Muchowski
Oct 29, 2008·Oncogene·A Hishiya, S Takayama
Jun 18, 2010·The Journal of Biological Chemistry·Rodrigo A FuentealbaRobert H Baloh
Mar 18, 2008·The Journal of Biological Chemistry·Gregory Pratt, Martin Rechsteiner
Dec 21, 2007·Molecular Biology of the Cell·Shoshiro HirayamaKazuhiro Nagata
Aug 7, 2009·Molecular Biology of the Cell·Peter M DouglasDouglas M Cyr
Mar 18, 2011·Molecular Biology of the Cell·Oishee ChakrabartiRamanujan S Hegde
Dec 3, 2010·Cold Spring Harbor Perspectives in Biology·R Martin VabulasF Ulrich Hartl
Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Steven Finkbeiner
Nov 19, 2008·Genes & Development·Martin L Duennwald, Susan Lindquist
Mar 10, 2009·Biochemistry. Biokhimii︠a︡·N BocharovaF Severin
Sep 20, 2011·The Journal of Clinical Investigation·Marianna SadagurskiMorris F White
Jun 4, 2013·The Journal of Clinical Investigation·Nataliya LutayCatharina Svanborg
Dec 19, 2006·Molecular Neurodegeneration·Shihua Li, Xiao-Jiang Li
May 16, 2007·PLoS Genetics·Linda S KaltenbachRobert E Hughes
Jan 7, 2011·PloS One·Patrick Lajoie, Erik Lee Snapp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.